Photodiagnosis and Photodynamic Therapy
Comparison of effects between daily repeated low-level red light therapy and 0.01% low-dose atropine for myopia prevention: A propensity score matching study
By Xiaoqian Ma, Yang Zhao, Yuanpei Zhou and 3 others.
Abstract
Objective
To compare the preventive effect of daily repeated low-level red light (RLRL) and 0.01% low-dose atropine eye drops (LDA) on myopia.
Methods
This was a 12-month prospective comparative study. 216 Children aged 7–12 years using either RLRL or LDA for myopia prevention were enrolled between July 10, 2024 to August 15, 2024. 192 completed the 12-month follow-up, last case went for clinical visit on August 28, 2025. The primary outcome was the 12-month myopia incidence. Secondary outcomes included changes in the spherical equivalent error (SER) and changes in the axial length (AL).
